{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-103959","form_type":"8-K","ticker":"HYPD","cik":"0001682639","company_name":"HYPERION DEFI, INC.","filed_at":"2024-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.103679+00:00","generated_at":"2026-05-31T00:46:16.243997+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Eyenovia prices $4M registered direct offering of common stock and warrants at $0.46/unit","bullets":["8,695,653 shares (or equivalents) and 8,695,653 warrants sold at $0.46 per share and accompanying warrant.","Gross proceeds ~$4M; closing expected September 30, 2024.","Warrants exercisable at $0.50/share, begin 6 months post-issuance, expire March 2030.","Net proceeds for Mydcombi and clobetasol commercialization, CHAPERONE myopia study, working capital, possible debt repayment.","Lead placement agent A.G.P./Alliance Global Partners; co-agent Brookline Capital Markets."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-103959","json":"https://secwatch.observer/filing/0001104659-24-103959.json","markdown":"https://secwatch.observer/filing/0001104659-24-103959.md","text":"https://secwatch.observer/filing/0001104659-24-103959.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1682639/000110465924103959/0001104659-24-103959-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1682639/000110465924103959/tm2425134d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T00:46:16.243997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}